Join the conversation

Track sentiment, discussions and live quotes, post ideas and see what real traders are doing

Loading...Loading...Loading...Loading...

Trending Tickers

GOOGL logo
Top trending tickerGOOGL
$290.90
9.26%
#1
Alphabets quarterly earnings shortfall and heavy AI infrastructure spending, which pressured free cash flow, are driving the selloff; traders also cite slowing search and advertising growth as concerns. Strong Google Cloud growth has led some investors to call the reaction excessive and buy the dip, while others question whether AI investment will produce sufficient returns.
GOOG logo
GOOG
$288.80
8.85%
#2
Alphabets earnings and revenue miss, alongside concerns about rising AI capital spending and cash burn, is driving the discussion. Traders are divided between viewing strong Google Cloud growth as evidence the investment is paying off and worrying that spending, slower search growth, and pressure on cash flow outweigh it.
NOW logo
NOW
$123.87
19.97%
#3
ServiceNows quarterly report sparked a sharp selloff despite solid revenue growth and a raised full-year outlook, as an earnings miss and slower-than-expected forward contracted-revenue growth raised concerns about decelerating momentum and a valuation priced for stronger results. Traders are split between calling the reaction an overreactionpointing to the companys AI opportunity and strong underlying growthand viewing the outlook as a reason for further caution.
MSFT logo
MSFT
$548.89
3.30%
#4
Microsofts fiscal first-quarter results beat expectations, with accelerating Azure growth and lower-than-expected capital spending prompting an initial bullish reaction. Traders remain divided over whether cloud momentum and spending discipline outweigh concerns about AI investment returns and cash flow, while some noted the post-earnings gains faded.
VKTX logo
VKTX
$24.62
1.08%
#5
Vikings Q3 earnings and conference call are driving attention, with traders weighing VK2735s Phase 3 progress and positive maintenance-study update against rising cash-burn concerns and uncertainty over commercialization, partnering, or going it alone. Reactions are split: some remain bullish on the obesity-drug pipeline and cash runway, while others criticize management and fear further dilution or a prolonged wait for clinical data.
QQQ logo
QQQ
$718.61
0.37%
#6
QQQ discussion centers on Alphabets earnings miss and concerns that heavy AI spending may not deliver adequate returns, with traders saying the reaction pressured tech indexes. Views are divided between fears of a broader AI-trade unwind and claims the selloff is overdone, while Microsofts results and the Feds rate hold offered counterpoints.
MRVL logo
MRVL
$229.83
5.64%
#7
Speculation that Marvell is in advanced talks to acquire Lumentum (LITE) is driving discussion, with traders weighing potential AI-optics and data-center synergies against concerns about the deals cost, dilution and financing. The report is treated as unconfirmed, and reactions include both support for the strategic fit and concern that it could pressure MRVL shares.
ORCL logo
ORCL
$141.02
8.04%
#8
Oracles investor-day outlook for strong long-term growth, a return to positive free cash flow, and capped additional financing eased concerns about AI infrastructure spending and debt, driving a sharp rally. Bulls welcomed the added clarity, while skeptics questioned whether the projections are achievable and pointed to the stocks pullback after its surge.
LITE logo
LITE
$1,016.50
17.35%
#9
Lumentum is drawing attention on reportstreated by traders as an unconfirmed rumorthat Marvell is in advanced talks to acquire it, which traders associate with LITEs sharp move higher. The community is split between takeover enthusiasm and skepticism about whether a deal is real, affordable, or beneficial to shareholders.
POET logo
POET
$6.00
5.45%
#10
Speculation about a potential MarvellLumentum deal has stirred POET traders, who debate whether optics-sector consolidation validates POETs optical-interposer technology and could make it an acquisition target, or instead raises competitive and component-supply risks. That optimism is tempered by doubts about whether POET can turn Lumilens-related development into commercial shipments, with investors looking for execution updates in the companys results.

About Stocktwits

With over 10 million users, Stocktwits helps you tap into the real-time sentiment and trending insights across stocks, ETFs, and crypto.